Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 11, 2023

BUY
$144.95 - $152.29 $14,929 - $15,685
103 Added 0.43%
24,238 $3.66 Million
Q3 2022

Nov 03, 2022

BUY
$144.95 - $152.29 $14,929 - $15,685
103 Added 0.43%
24,238 $3.66 Million
Q2 2022

Aug 11, 2023

BUY
$83.14 - $145.99 $189,725 - $333,149
2,282 Added 10.44%
24,135 $3.52 Million
Q2 2022

Aug 15, 2022

BUY
$83.14 - $145.99 $189,725 - $333,149
2,282 Added 10.44%
24,135 $3.52 Million
Q1 2022

Aug 11, 2023

BUY
$110.08 - $142.92 $2.41 Million - $3.12 Million
21,853 New
21,853 $2.59 Million
Q1 2022

May 20, 2022

SELL
$110.08 - $142.92 $574,067 - $745,327
-5,215 Reduced 19.27%
21,853 $2.59 Million
Q4 2021

Feb 16, 2022

SELL
$99.73 - $148.48 $34,406 - $51,225
-345 Reduced 1.26%
27,068 $3.73 Million
Q3 2021

Nov 12, 2021

SELL
$98.85 - $138.91 $182,081 - $255,872
-1,842 Reduced 6.3%
27,413 $3.81 Million
Q2 2021

Aug 12, 2021

BUY
$65.78 - $105.02 $204,773 - $326,927
3,113 Added 11.91%
29,255 $2.84 Million
Q1 2021

May 03, 2021

SELL
$64.07 - $91.75 $104,049 - $149,002
-1,624 Reduced 5.85%
26,142 $1.79 Million
Q4 2020

Feb 12, 2021

BUY
$65.07 - $98.24 $66,371 - $100,204
1,020 Added 3.81%
27,766 $2.38 Million
Q3 2020

Nov 09, 2020

SELL
$59.04 - $77.95 $16,944 - $22,371
-287 Reduced 1.06%
26,746 $1.74 Million
Q2 2020

Aug 10, 2020

BUY
$29.01 - $74.23 $49,317 - $126,191
1,700 Added 6.71%
27,033 $1.87 Million
Q1 2020

May 15, 2020

BUY
$27.51 - $57.29 $79,613 - $165,797
2,894 Added 12.9%
25,333 $862,000
Q4 2019

Feb 14, 2020

SELL
$40.86 - $57.65 $14,954 - $21,099
-366 Reduced 1.6%
22,439 $1.03 Million
Q3 2019

Nov 12, 2019

BUY
$37.38 - $49.47 $112,252 - $148,558
3,003 Added 15.17%
22,805 $947,000
Q2 2019

Aug 14, 2019

BUY
$39.79 - $67.01 $10,265 - $17,288
258 Added 1.32%
19,802 $867,000
Q1 2019

May 13, 2019

BUY
$34.52 - $53.29 $75,184 - $116,065
2,178 Added 12.54%
19,544 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$29.75 - $42.9 $19,605 - $28,271
-659 Reduced 3.66%
17,366 $642,000
Q3 2018

Nov 14, 2018

SELL
$32.79 - $43.0 $53,972 - $70,778
-1,646 Reduced 8.37%
18,025 $677,000
Q2 2018

Aug 14, 2018

SELL
$23.62 - $42.29 $75,300 - $134,820
-3,188 Reduced 13.95%
19,671 $777,000
Q1 2018

May 15, 2018

BUY
$22.49 - $34.56 $334,493 - $514,010
14,873 Added 186.24%
22,859 $589,000
Q3 2017

Nov 14, 2017

BUY
$23.54 - $38.21 $187,990 - $305,145
7,986
7,986 $298,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.